Viral Hepatitis and Drug Use in Europe

Hepatitis – a devastating epidemic in Europe

Authors: Jeffrey V Lazarus and Kevin A Fenton

No strategy to meet the HCV epidemic

Authors: Olav Dalgard and Stefan Mauss

Improved hepatitis C screening and treatment in people who inject drugs should be a priority in Europe

Authors: Achim Kautz, Lilyana Chavdarova and Margaret Walker

Ending the mass criminalisation of people who use drugs: a necessary component of the public health response to hepatitis C

Authors: Chris Ford and Juliet Bressan

A treatment revolution for those who can afford it? Hepatitis C treatment: new medications, profits and patients

Authors: Maria Phelan and Catherine Cook

A national multidisciplinary healthcare network for treatment of hepatitis C in people who inject drugs in Slovenia

Authors: Mojca Maticic

The successful implementation of Scotland’s Hepatitis C Action Plan: what can other European stakeholders learn from the experience? A Scottish voluntary sector perspective

Authors: Leon Wylie, Sharon Hutchinson, David Liddell and Nicola Rowan

Improving the quality of needle and syringe programmes: an overlooked strategy for preventing hepatitis C among people who inject drugs

Authors: Astrid Leicht

Consensus for the integrated management of hepatitis C in Portugal

Authors: Ricardo Baptista Leite

A perspective from drug user organisations on ‘ECDC and EMCDDA guidance: prevention and control of infectious diseases among people who inject drugs’

Authors: Antonio Corbacho, Manuel Rivera, Francisco Trujillo, Maite Martí, José Carbonell, Francisco Fernández, Alexandre Rosselló, Jordi Perramon, Jaume Salse and Ignacio Ramos

A policy-maker’s perspective on ‘ECDC and EMCDDA guidance: prevention and control of infectious diseases among people who inject drugs’

Authors: Joan Colom I Farran

Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities

Behavioural surveillance among people who inject drugs (PWID) and testing for hepatitis C virus (HCV) and HIV is needed to understand the scope of both epidemics in at-risk populations and to suggest steps to ...

Authors: Robert Heimer, Ksenia Eritsyan, Russell Barbour and Olga S Levina

HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective

Authors: Lars Peters, Amanda Mocroft, Jens Lundgren, Daniel Grint, Ole Kirk and Jürgen Kurt Rockstroh

Are there national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs? A survey of 33 European countries

Hepatitis C virus (HCV) infection represents a major global health problem, which in high-income countries now mostly affects people who inject drugs (PWID). Many studies show that the treatment of HCV infecti...

Authors: Mojca Maticic, Jerneja Videcnik Zorman, Sergeja Gregorcic, Eberhard Schatz and Jeffrey V Lazarus

Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey

Unsafe injections, through infectious bodily fluids, are a major route of transmission for hepatitis B and C. Viral hepatitis burden among people who inject drugs is particularly high in many Member States of ...

Authors: Alexander Spina, Irina Eramova and Jeffrey V Lazarus

A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region

Fifteen million adults in the World Health Organization European Region are estimated to have active hepatitis C infection. Intravenous drug use is a major hepatitis C transmission route in this region, and pe...

Authors: Jeffrey V Lazarus, Ida Sperle, Mojca Maticic and Lucas Wiessing

Hepatitis C in European prisons: a call for an evidence-informed response

Globally, over 10 million people are held in prisons and other places of detention at any given time. People who inject drugs (PWID) comprise 10-48% of male and 30-60% of female prisoners. The spread of hepati...

Authors: Amber Arain, Geert Robaeys and Heino Stöver

Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis

Authors: Jeffrey V Lazarus, Jens Lundgren, Jordi Casabona, Lucas Wiessing, Catharina Matheï, Peter Vickerman, Maria Prins, Mirjam Kretzschmar, Maria Kantzanou, Isabelle Giraudon, Marica Ferri, Paul Griffiths, Magdalena Harris, Margaret Walker, Lilyana Chavdarova, Eberhard Schatz…